{
    "2020-04-02": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Novartis Terminates Sale of Sandoz Dermatology Business",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Terminates",
                        "Sale",
                        "Sandoz",
                        "Dermatology"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Scraps",
                        "Deal",
                        "Sandoz",
                        "Assets",
                        "Nevro",
                        "Q1 Shortfall",
                        "Affimed",
                        "Orphan Drug"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novartis scraps sale of assets including COVID-19 hopeful to Aurobindo Pharma",
                "features": {
                    "keywords": [
                        "Novartis",
                        "scraps",
                        "sale",
                        "assets",
                        "COVID-19",
                        "Aurobindo Pharma"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}